QYLD vs XLV
Global X Nasdaq 100 Covered Call ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.60% for QYLD.
- • QYLD pays a higher dividend yield (11.47%).
Side-by-side metrics
| Metric | QYLD | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.08% |
Dividend yield Trailing 12-month yield. | 11.47% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $8.33B | $37.88B |
YTD return | 6.64% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.49 | 0.58 |
P/E ratio | 32.79 | 26.68 |
Last price | $18.10 | $144.72 |
Inception | — | — |
Issuer | Global X | State Street |
QYLD top holdings
| NVDA | NVIDIA Corp | 8.85% |
| AAPL | Apple Inc | 7.27% |
| MSFT | Microsoft Corp | 5.52% |
| AMZN | Amazon.com Inc | 5.19% |
| GOOGL | Alphabet Inc Class A | 4.09% |
| GOOG | Alphabet Inc Class C | 3.79% |
| AVGO | Broadcom Inc | 3.61% |
| TSLA | Tesla Inc | 3.47% |
| META | Meta Platforms Inc Class A | 3.29% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About QYLD
QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.3B in assets under management, an expense ratio of 0.60%, a dividend yield of 11.47%. Its largest holding is NVIDIA Corp (NVDA), which represents 8.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.1%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.